期刊文献+

利莫那班对血管紧张素Ⅱ诱导心肌细胞肥大的抑制作用及其机制研究

Inhibitory Effects of Rimonabant on Cardiomyocyte Hypertrophy Induced by Angiotensin Ⅱ and Its Mechanism Study
下载PDF
导出
摘要 目的:研究利莫那班对血管紧张素Ⅱ(AngⅡ)诱导心肌细胞肥大的抑制作用及其机制。方法:取大鼠心肌细胞接种于6孔板中,密度调整为2×105L^(-1),分为空白对照组、模型组、阳性对照组(氯沙坦10μmol/L)和利莫那班低、中、高浓度组 (0.1、1.0、5.0μmol/L),后5组加入0.1μmol/L AngⅡ建立心肌肥大细胞模型,然后分别加入相应浓度的药物,培养24 h后,观察并测量每一个视野内球形细胞的直径和细胞数量,检测心肌细胞中Ca^(2+)浓度、一氧化氮(NO)含量、一氧化氮合酶(NOS)活性和Ⅰ型大麻受体(CB_1)蛋白表达情况。结果:各组心肌细胞数量差异无统计学意义(P>0.05)。与空白对照组比较,模型组心肌细胞直径明显增大,心肌细胞中Ca^(2+)浓度和CB1蛋白表达水平均明显增加,NO含量和NOS活性明显降低,差异均有统计学意义(P<0.05)。与模型组比较,阳性对照组和利莫那班低、中、高浓度组心肌细胞直径明显缩小,心肌细胞中Ca^(2+)浓度和CB_1蛋白表达水平均明显降低,NO含量和NOS活性明显增加,差异均有统计学意义(P<0.05),且利莫那班组作用呈浓度依赖性。结论:利莫那班可抑制AngⅡ诱导的心肌细胞肥大,其作用机制可能与降低Ca^(2+)浓度、下调CB_1蛋白表达有关。 OBJECTIVE:To study the inhibitory effects of rimonabant on cardiomyocyte hypertrophy induced by angiotensinⅡ(AngⅡ)and its mechanisms.METHODS:Rat cardiomyocytes were incubated in 6 well culture plates with density of 2×105 L-1.They were divided into blank control group,model group,positive control group(losartan10μmol/L),rimonabant lowconcentration,medium-concentration and high-concentration groups(0.1,1.0,5.0μmol/L).The latter 5 groups were cultured with 0.1μmol/L AngⅡto induce cardiomyocyte hypertrophy model,and then given relevant concentration of drugs.After cultured with 24 h,diameter and number of spherical cells in each field of vision were observed and measured.The Ca2+concentration,NO content,NOS activity and protein expression of cannabinoid receptor 1(CB1)in cardiomyocyte were determined.RESULTS:There was no statistical significance in the number of cardiomyocyte(P>0.05).Compared with blank control group,the diameter of cardiomyocytes in model group increased,and Ca2+concentration and protein expression of CB1 in cardiomyocytes were increased significantly;NO content and NOS activity decreased significantly,with statistical significance(P<0.05).Compared with model group,the diameter of cardiomyocytes in positive control group,rimonabant low-concentration,medium-concentration and high-concentration groups were decreased significantly,and Ca2+concentration and protein expression of CB1 in cardiomyocytes were decreased significantly;NO content and NOS activity increased significantly,with statistical significance(P<0.05),and the effects of the rimonabant groups were dose-dependent.CONCLUSIONS:Rimonabant can inhibite cardiomyocyte hypertrophy induced by AngⅡ,the mechanism of which may be associated with the decrease of Ca2+concentration and protein expression of CB1.
作者 扈晓霞 韩世飞 李晶 HU Xiaoxia;HAN Shifei;LI Jing(Dept.of Cardiovascular Medicine,Harrison International Peace Hospital,Hebei Hengshui 053000,China;Dept.of Pharmacy,Chongqing Three Gorges Central Hospital,Chongqing 404000,China)
出处 《中国药房》 CAS 北大核心 2018年第21期2921-2925,共5页 China Pharmacy
基金 重庆市基础研究与前沿探索项目(No.cstc2018jcyjAX0723) 重庆市社会民生科技创新专项(No.cstc2016shmszx130028)
关键词 利莫那班 血管紧张素Ⅱ 心肌细胞肥大 Ca2+浓度 Ⅰ型大麻受体 Rimonabant AngiotensinⅡ Cardiomyocyte hypertrophy Ca2+concentration Cannabinoid receptor 1
  • 相关文献

参考文献8

二级参考文献55

  • 1李立明,饶克勤,孔灵芝,姚崇华,向红丁,翟凤英,马冠生,杨晓光,中国居民营养与健康状况调查技术执行组.中国居民2002年营养与健康状况调查[J].中华流行病学杂志,2005,26(7):478-484. 被引量:1783
  • 2[1]Alan H,Fadi A.From left ventricular hypertrophy to congestive heart failure:management of hypertensive heart disease[J].Progress in Cardiovascular Disease,2006,48,326-341.
  • 3[2]Kiyoshi M,Koji F,Hideyuki O,et al.Role of aldosterone in left ventricular hypertrophy in hypertension[J].AJH,2006,19,13-18.
  • 4[3]Devereux RB,Palmieri V,Sharpe N,et al.Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based anti-hypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension:the prospective randomized enalapril study evaluating regression of ventricular enlargement (preserve) trial[J].Circulation,2001,104:1248-1254.
  • 5[4]Klingbeil AU,Schneider M,Martus P,et al.A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension[J].Am J Med,2003,115:41-46.
  • 6[5]Arsalan S,karl T.Extracellular matrix remodeling in hypertensive heart disease[J].JACC,2006,48:1-2.
  • 7[6]Rubattu S,Bigatti G,Evangelista A,et al.Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension[J].JACC,2006,48,499-505.
  • 8[7]Taniguchi I,Kawai M,Date T,et al.Effects of spironolactone during an angiotensin Ⅱ receptor blocker treatment on the left ventricular mass reduction in hypertensive patients with concentric left ventricular hypertrophy[J].Circ J,2006,70:995-1000.
  • 9[8]Krauser DG,Devereux RB.Ventricular hypertrophy and hypertension:Prognostic elements and implication for management[J].Herz,2006,31:305-316.
  • 10[9]Matsumura K,Ohtsubo T,Oniki H.Gender-related association of serum uric acid and left ventricular hypertrophy in hypertension[J].Circ J,2006,70:885-888.

共引文献195

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部